Eloxx Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest ELOX financial statements, income statements and financial ratios.

The price trend for Senesco Technologies Inc. (ELOX) has been bearish lately and the stock has lost 10.3% over the past week. However, the formation of a hammer chart pattern in its last trading ...

Eloxx Pharmaceuticals, Inc. ELOX has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope ...

Eloxx Pharmaceuticals, Inc. ELOX shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55. Oppenheimer analyst Hartaj Singh maintained coverage on Eloxx ...

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 ...

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused ...

Eloxx Pharmaceuticals, Inc. ELOX has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope ...

Eloxx Pharmaceuticals Inc. Annual cash flow by MarketWatch. View ELOX net cash flow, operating cash flow, operating expenses and cash dividends.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...